降低处方的成本和后果分析,以优化脆弱老年人的健康结果:试验内部分析
Charles E Okafor1, Syed Afroz Keramat1, Tracy Comans1
1Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Journal of the American Medical Directors Association
|February 2, 2024
概括
在老年护理设施中停止处方药物是节省成本的,不会降低生活质量. 这一策略为澳大利亚的卫生系统提供了显著的潜在净储蓄.
科学领域:
- 老年医学 老年医学
- 卫生经济学 卫生经济学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多药性是老年护理的一个重要问题,需要像抑郁症这样的策略.
- 住院养老机构 (RACF) 的脆弱老年人特别容易受到不适当药物使用的风险的影响.
研究的目的:
- 评估澳大利亚RACF中结构化减记干预 (Opti-Med) 的经济成本和后果.
- 评估抑郁症对药物成本和质量调整寿命 (QALYs) 的影响.
主要方法:
- 在Opti-Med随机对照试验中进行了试验内成本后果分析.
- 该研究包括西澳大利亚和新南威尔士17个RACF的303名参与者.
- 从卫生部门的角度分析了健康经济结果,其成本为2022澳元.
主要成果:
- 这项Opti-Med干预每名参与者的费用为239.13美元.
- 在12个月内,每位参与者从处方药中节省的成本为328.90美元 (失明) 和164.00美元 (开放).
- 澳大利亚卫生系统每年可能节省1至1600万澳元的国家净储蓄.
- 所有试验组的增量QALY都是可比的.
结论:
- 降低处方是RACF中脆弱的老年人节省成本的干预措施,保持生活质量.
- 系统范围内的实施可以优化医疗保健服务,并允许在老年护理中重新投资成本节省.
- 停止处方是一种有价值的策略,可以改善住院养老院的药物管理和健康结果.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Analysis of Population Pharmacokinetic Data
257
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
257
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Strategies for Assessing and Addressing Confounding
101
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
101


